Shopping Cart
- Remove All
- Your shopping cart is currently empty
LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,570 | 10-14 weeks | |
50 mg | $3,380 | 10-14 weeks | |
100 mg | $4,600 | 10-14 weeks |
Description | LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells. |
Targets&IC50 | mGluR3:1.05 μM, mGluR2:0.161 μM |
In vivo | LY 541850 (intraperitoneal injection;?10 mg/kg-300 mg/kg;?30 min prior) reduces the increased locomotor activity of phencyclidine and amphetamine in a dose-dependent manner in male ICR mice[1]. |
Molecular Weight | 199.2 |
Formula | C9H13NO4 |
Cas No. | 852679-76-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.